ASHG 2026 · Tier 2–3 Academic

Hamad bin Khalifa University at ASHG 2026

Name: ASHG 2026 Annual Meeting
Start: 2026-10-20
End: 2026-10-24
Location: Montréal

Doha, Qatar

Hamad bin Khalifa University at ASHG 2026 in Montréal: 9 presentations (7 posters, 2 platform talks); 6 research groups.

presentations on the program

research groups identified

sessions invited to or moderated

Explore everyone at ASHG 2026 →

Organization	ASHG 2026 Attendance
Hamad bin Khalifa University Doha, Qatar	3 PIs · 2 PhD Students · 2 Postdocs · 1 Staff Scientist
Genomics and Translational Biomedicineelmi.hbku.edu.qa/en/organisations/genomics-and-translational-biomedicine/persons Wet + dry lab~6 people Studies pharmacogenomics, whole-genome sequencing and metabolomics in Qatari cohorts. Projects target personalized treatment in Qatari patients. 39 papers since 2024 › Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia JAMA Cardiology, 2024 Turicibacter and Catenibacterium as potential biomarkers in autism spectrum disorders Scientific Reports, 2024 ABC transporter inhibition by beauvericin partially overcomes drug resistance in Leishmania tropica Antimicrobial Agents and Chemotherapy, 2024 Source: OpenAlex author A5005384946 Funded by QNRF, HBKU-OVPR +2 more › QNRF, EX-QNRF-PPM-61 · 24/03/26 → 24/03/29 ““EX-QNRF-PPM-61: Implementing Infectious Disease Pharmacogenomics in Qatar”; “24/03/26 → 24/03/29”” HBKU-OVPR, HBKU-OVPR-TG-03-46 · 1/11/25 → 31/10/27 ““HBKU-OVPR-TG-03-46: Investigating DUSP5 as a modulator of cancer immunity in triple negative breast cancer”; “1/11/25 → 31/10/27”” QNRF, EX-QNRF-PPM-24 · 1/01/24 → 1/01/27 ““EX-QNRF-PPM-24: Integrating metabolomics, microbiomics, and pharmacogenomics for personalized metformin treatment in Qatari type 2 diabetes patients”; “1/01/24 → 1/01/27”” +1 more on the lab page Source: lab pages 9 platforms and techniques › Analyzes whole genome sequencing, whole genome bisulfite sequencing Techniques pharmacogenomics, metabolomics, microbiomics, CRISPR-Cas9 functional screens, generative AI, bioinformatics analysis, cell line multi-omics Source: lab pages No openings posted	Poster Wed Oct 21 2:30 pm Decoding the Genetic Architecture of Adverse Drug Reactions: A Mendelian Randomization Study of 21 Medications Across 99 Phenotypes Statistical Genetics and Genetic Epidemiology Collaborators: University of Liverpool Genome-wide association studyMendelian randomizationPrecision medicine Poster Thu Oct 22 4:15 pm SDR42E1 ortholog deficiency uncovers conserved sterol-metabolic pathways influencing lifespan in C. elegans Molecular Effects of Genetic Variation Collaborators: Applied Science Private University Genome editing/CRISPRRNA-seqEndocrine systemCellular metabolism Poster Thu Oct 22 4:15 pm Population-Scale Pharmacogenomics in Qatar Reveals High Burden of Preventable Adverse Drug Reactions Pharmacogenomics Collaborators: University of Liverpool Electronic health recordsExome/genome sequencingPharmacogenomicsPopulation genetics Poster Fri Oct 23 2:30 pm Integrative transcriptomic and Mendelian randomization analysis of metformin-related genes across glycemic traits and colorectal cancer Statistical Genetics and Genetic Epidemiology Metabolic disorderDiabetesGenetic epidemiologyMendelian randomization
AI for Disease Analysisqcai.qcri.org/research/ai-for-precision-health/ai-for-disease-analysis Dry lab~8 people Integrates whole-genome sequencing, metabolomics, proteomics, medical imaging and EHR data with AI. Supports biomarker discovery, disease-risk prediction and Middle Eastern precision health. Funded by Path to Precision Medicine, Qatar Precision Health Institute › Path to Precision Medicine, 6th Cycle · active “Path to Precision Medicine – 6th Cycle” Qatar Precision Health Institute, Research Program · active “Qatar Precision Health Institute Research Program” Source: lab pages 13 platforms and techniques › Analyzes whole-genome sequencing, metabolomics, proteomics, medical imaging, electronic health records (EHRs) Techniques Artificial Intelligence and Machine Learning, Deep Learning for Healthcare, Multi-Omics Data Integration, Polygenic Risk Score Development, Statistical Genetics and Genomic Analysis, Rare Variant Association Studies, Predictive Modeling and Clinical Risk Stratification, Electronic Health Record Analytics Source: lab pages No openings posted	Talk Fri Oct 23 11:30 am Large-scale Multi-omics Analyses of Cardiometabolic Traits in the Middle East Genetics of Cardiometabolic Traits Cardiovascular systemGenomicsGenome-wide association studyGenotype-phenotype correlations
Cancer Biomarker Discovery and Therapeutic Targetinghbku.edu.qa/en/qbri/research-teams-research-group_dr-nehad-alajez Wet + dry lab~8 people Studies breast cancer using lncRNA transcriptome data, microRNA and lncRNA, and CRISPR-Cas9 functional screens. Identifies diagnostic, prognostic and treatment-response biomarkers, especially in triple-negative breast cancer. 30 papers since 2024 › Apigenin and Rutaecarpine reduce the burden of cellular senescence in bone marrow stromal stem cells Frontiers in Endocrinology, 2024 Unified mRNA Subcellular Localization Predictor based on machine learning techniques BMC Genomics, 2024 Disrupted Lipid Metabolism, Cytokine Signaling, and Dormancy: Hallmarks of Doxorubicin-Resistant Triple-Negative Breast Cancer Models Cancers, 2024 Source: OpenAlex author A5014280161 3 platforms and techniques › Techniques CRISPR-Cas9 genome-editing functional screens, Transcriptome analysis, lncRNA transcriptome profiling Source: lab pages No funding stated · No openings posted	Talk Sat Oct 24 10:15 am Genome-scale screening identifies lncRNA vulnerabilities in triple-negative breast cancer Cancer Under Pressure: Genomics of Therapy Response and Resistance CancerEpigeneticsNon-coding RNAMolecular therapeutics
Genomics of Neurodevelopmental Disordershbku.edu.qa/en/qbri/research-teams-dr-jouke-jan-hottenga Wet + dry lab~4 people Studies genomics and multi-omics data across population-based datasets using bioinformatics, statistical modeling and AI. Investigates prioritized variants in cellular models for precision medicine. 61 papers since 2024 › Genome-wide characterization of circulating metabolic biomarkers Nature, 2024 Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits Nature Genetics, 2024 Genome-wide association study reveals mechanisms underlying dilated cardiomyopathy and myocardial resilience Nature Genetics, 2024 Source: OpenAlex author A5029024758 6 platforms and techniques › Techniques bioinformatics, statistical modelling, AI, cellular models, genome-wide association studies, meta-analyses Source: lab pages No funding stated · No openings posted	Poster Thu Oct 22 4:15 pm Genomic analyses reveal novel autism spectrum disorder risk genes in a Middle Eastern Qatari cohort Molecular Effects of Genetic Variation Collaborators: Laboratory for Research on Enterprise and Decisions AutismCandidate geneConsanguinityGenetic variation
Qatar Center for Artificial Intelligenceqcai.qcri.org Dry lab~37 people Develops AI methods on whole-genome sequencing, metabolomics, proteomics, imaging and EHR data. Uses data for biomarkers, disease-risk prediction and patient stratification in Middle Eastern populations. 37 papers since 2024 › Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023 The Lancet. Gastroenterology & hepatology, 2026 Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis The Lancet Global Health, 2025 The predictors of successful methotrexate treatment of tubal ectopic pregnancy Journal of Obstetrics and Gynaecology, 2024 Source: OpenAlex author A5039702758 Funded by Path to Precision Medicine, Qatar Precision Health Institute › Path to Precision Medicine, 6th Cycle · active “Path to Precision Medicine – 6th Cycle” Qatar Precision Health Institute, Qatar Precision Health Institute Research Program · active “Qatar Precision Health Institute Research Program” Source: lab pages 16 platforms and techniques › Analyzes whole-genome sequencing, RNA-Seq, metabolomics, proteomics, Qatar Biobank, Qatar Genome Program, UK Biobank, All of Us Research Program Techniques Artificial Intelligence and Machine Learning, Deep Learning for Healthcare, Multi-Omics Data Integration, Polygenic Risk Score Development, Statistical Genetics and Genomic Analysis, Rare Variant Association Studies, Predictive Modeling and Clinical Risk Stratification, Electronic Health Record Analytics Source: lab pages Currently hiring › “We are seeking exceptional talent across our research and engineering tracks” Source: lab positions page	Moderator Thu Oct 22 8:15 am From Labels to Landscapes: Leveraging Local Ancestry and the Ancestry Continuum to Maximize Cross-Ancestry Association Poster Thu Oct 22 4:15 pm Leveraging Runs of Homozygosity to Identify Rare Susceptibility Loci for Cardiometabolic Traits in Middle Eastern individuals Statistical Genetics and Genetic Epidemiology Collaborators: Université Paris-Saclay Genetic epidemiologyConsanguinityCardiovascular system
QBRI - Neurological Disorders Research Centerhbku.edu.qa/en/qbri/neurological-disorders-research-center Wet + dry lab Uses whole-genome sequencing, proteomics, metabolic studies, stem cells and organoids to study neurological disorders. Partners Qatar Biobank on biomarkers and therapies. Funded by QNRF, QBRI Research Grants › QNRF, ANMR · 2026-2028 “Proposal ID \| EX-QNRF-ANMR-14. Status \| Active. Effective start/end date \| 1/03/26 → 1/03/28” QBRI Research Grants · 2026-2028 “QBRI Research Grants. Status \| Active. Effective start/end date \| 1/03/26 → 1/03/28” Source: lab pages 13 platforms and techniques › Works with Whole-genome sequencing, Filter retardation assay, Surface plasmon resonance (SPR), ELISA-based epitope mapping, α-synuclein aggregation inhibition assays Techniques Experimental disease modeling, Biomarker analyses, Gene therapy, Stem cell biology, Organoid models, Nanobody engineering, PD cell models, PFFs PD mouse models Source: lab pages No openings posted	Poster Thu Oct 22 4:15 pm Whole-genome sequencing reveals the rare variant landscape and novel candidate genes in a Qatari autism spectrum disorder cohort Genetic Therapies and Precision Medicine AutismCandidate geneExome/genome sequencingGenetic variation

Meeting Hamad bin Khalifa University in Montréal?

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction